Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) – Industry Trends and Forecast to 2031.
.
The Global Topical Drug Delivery Market size was valued at USD 116.30 USD Billion in 2023.
The Global Topical Drug Delivery Market is projected to grow at a CAGR of 6.9% during the forecast period of 2024 to 2031.
The major players operating in the market include , Johnson & Johnson Private Limited , Nestlé India , Novartis AG , GlaxoSmithKline plc , Bausch Health Companies , Merck & Co , Bayer AG , Hisamitsu Pharmaceutical Co. , Glenmark Pharmaceuticals Limited , Cipla , Crescita Therapeutics , Mylan N.V. , Encore Dermatology , LEO Pharma A/S , Almirall S.A , Aclaris Therapeutics , Taro Pharmaceutical Industries , Teligent , Perrigo Company plc , Allergan , Biofrontera AG , Crown , Akorn Operating Company LLC. , Ingenus , Sun Pharmaceutical Industries ,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
